Changes in percutaneous coronary intervention practice in Japan during the COVID‐19 outbreak: LIFE Study
| Autor: | Ryusuke Miki, Kosuke Kiyohara, Haruhisa Fukuda, Tetsuhisa Kitamura, Megumi Maeda |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Acute coronary syndrome
medicine.medical_specialty medicine.medical_treatment Disease 030204 cardiovascular system & hematology Brief Communication 03 medical and health sciences symbols.namesake 0302 clinical medicine emergency medicine elective surgical procedure Medicine 030212 general & internal medicine Poisson regression RC86-88.9 business.industry Incidence (epidemiology) percutaneous coronary intervention General Engineering Percutaneous coronary intervention Outbreak Medical emergencies. Critical care. Intensive care. First aid COVID‐19 pandemic medicine.disease Conventional PCI Emergency medicine symbols Brief Communications business Elective Surgical Procedure |
| Zdroj: | Acute Medicine & Surgery Acute Medicine & Surgery, Vol 8, Iss 1, Pp n/a-n/a (2021) |
| ISSN: | 2052-8817 |
| DOI: | 10.1002/ams2.638 |
| Popis: | Aim The global outbreak of coronavirus disease (COVID‐19) has had widespread effects on clinical practice, and is reportedly associated with reduced percutaneous coronary intervention (PCI) rates in the US and Italy. This study aimed to ascertain the influence of the COVID‐19 outbreak on PCI practice in Japan. Methods In a retrospective analysis of claims data from National Health Insurance and Later‐Stage Elderly Healthcare System enrollees in Kobe City, Japan, we examined the changes in PCI incidence before and during the COVID‐19 outbreak. Percutaneous coronary intervention incidence during the COVID‐19 outbreak in 2020 was compared with that of the same (pre‐outbreak) period in 2019 using a Poisson regression analysis with the monthly number of PCIs as the dependent variable. Results A total of 639 patients underwent PCI in Kobe City between February and May 2020. The results showed a 19% reduction in all PCI procedures during the outbreak relative to the pre‐outbreak period (P = 0.001). There were no significant changes in non‐elective PCIs for acute coronary syndrome (ACS) cases, but a 25% reduction in elective PCIs for non‐ACS cases (P The global outbreak of COVID‐19 has had profound and far‐reaching effects on clinical practice, and is reported to be associated with a reduction in percutaneous coronary intervention (PCI) rates in the US and Italy. We examined the changes in PCI incidence during the COVID‐19 outbreak using claims data from Kobe City. There was no significant changes in Acute coronary syndrome (ACS) including STEMI and non‐STEMI cases, but a 23% reduction in PCIs for non‐ACS cases (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text